Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEPW) Short Interest Update

Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEPW) was the recipient of a significant growth in short interest in the month of February. As of February 27th, there was short interest totaling 7,403 shares, a growth of 1,991.2% from the February 12th total of 354 shares. Based on an average daily trading volume, of 8,290 shares, the short-interest ratio is presently 0.9 days. Based on an average daily trading volume, of 8,290 shares, the short-interest ratio is presently 0.9 days.

Coeptis Therapeutics Stock Up 24.2%

Shares of COEPW stock traded up $0.00 during trading on Thursday, reaching $0.01. 106,200 shares of the company’s stock were exchanged, compared to its average volume of 25,350. Coeptis Therapeutics has a twelve month low of $0.00 and a twelve month high of $0.05. The firm’s fifty day moving average price is $0.01 and its 200-day moving average price is $0.02.

Coeptis Therapeutics Company Profile

Coeptis Therapeutics is a clinical‐stage biopharmaceutical company focused on developing novel therapies for neurodegenerative and neuroinflammatory disorders. The company’s proprietary platform is based on engineered analogs of small heat shock proteins designed to modulate cellular stress responses, reduce inflammation and protect neurons from degeneration. Coeptis’s lead program is being advanced in amyotrophic lateral sclerosis (ALS), with additional preclinical studies underway in conditions such as multiple sclerosis and other central nervous system diseases.

Using its heat shock protein analog technology, Coeptis seeks to address the underlying pathology of neurodegeneration rather than merely managing symptoms.